Literature DB >> 26319123

Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.

Hyung Jun Park1, Ji-Man Hong2, Jung Hwan Lee2, Hyung Seok Lee2, Ha Young Shin2, Seung Min Kim2, Chang-Seok Ki3, Ji Hyun Lee4, Young-Chul Choi5.   

Abstract

The objective of this study was to investigate the clinical and genetic features of Korean patients with facioscapulohumeral muscular dystrophy type 1 (FSHD), and assessed the impact of molecular defects on phenotypic expression. We enrolled 104 FSHD patients from 87 unrelated Korean families with D4Z4 repeat array of less than 11 copies on 4q35. Sixty-one men and forty-three women were enrolled. Median D4Z4 copy number was 4 units and 99 (95%) Korean patients with FSHD carried 1-6 units. The median age at symptom onset was 13 [interquartile range: 8-17] years old. In 100 symptomatic patients, muscle weakness began in facial muscles in 58 patients, shoulder-girdle muscles in 37, and pelvic-girdle muscles in 5. Disease severity was significantly correlated with D4Z4 copy number. In addition, women were more severely affected than men even though there were no differences in age at examination or in D4Z4 copy number between the two genders. This gender difference among Korean patients was the opposite of analysis on individuals of European ancestry. In conclusion, the present study demonstrated the new diagnostic threshold for FSHD in Koreans based on the D4Z4 repeat array size distribution from 1 to 6 units and expanded the clinical spectrum.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  D4Z4 repeat; Facioscapulohumeral muscular dystrophy; Gender difference; Genotype–phenotype relationship

Mesh:

Year:  2015        PMID: 26319123     DOI: 10.1016/j.nmd.2015.08.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.

Authors:  Chen-Yu Wang; Harrison Brand; Natalie D Shaw; Michael E Talkowski; Jeannie T Lee
Journal:  Genetics       Date:  2019-08-16       Impact factor: 4.562

2.  SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.

Authors:  Richard J L F Lemmers; Nienke van der Stoep; Patrick J van der Vliet; Steven A Moore; David San Leon Granado; Katherine Johnson; Ana Topf; Volker Straub; Teresinha Evangelista; Tahseen Mozaffar; Virginia Kimonis; Natalie D Shaw; Rita Selvatici; Alessandra Ferlini; Nicol Voermans; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Meindert Lamers; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2019-06-26       Impact factor: 6.318

3.  FAT1 Gene Alteration in Facioscapulohumeral Muscular Dystrophy Type 1.

Authors:  Hyung Jun Park; Wookjae Lee; Se Hoon Kim; Jung Hwan Lee; Ha Young Shin; Seung Min Kim; Kee Duk Park; Ji Hyun Lee; Young Chul Choi
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

4.  Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease.

Authors:  Daniel Zielonka; Barbara Stawinska-Witoszynska
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 5.  Does DNA Methylation Matter in FSHD?

Authors:  Valentina Salsi; Frédérique Magdinier; Rossella Tupler
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

6.  Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.

Authors:  Zhiqiang Wang; Liangliang Qiu; Minting Lin; Long Chen; Fuze Zheng; Lin Lin; Feng Lin; Zhixian Ye; Xiaodan Lin; Junjie He; Lili Wang; Xin Lin; Qifang He; Wanjin Chen; Yi Lin; Ying Fu; Ning Wang
Journal:  Lancet Reg Health West Pac       Date:  2021-11-22

7.  Joining mainstream research on Facioscapulohumeral Dystophy: disease prevalence in China.

Authors:  Frédérique Magdinier
Journal:  Lancet Reg Health West Pac       Date:  2021-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.